Loading institutional data...
Loading institutional data...
Held by 309 of 5,944 reporting institutions (94th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $42.92 today, the market must believe free cash flow compounds 8.6%/yr for a decade (off $109M normalized FCF).
The market's 8.6% is more optimistic than its 9-yr track record.
2-stage DCF · 0.06B shares · net debt -$128M
mean 9.8% · volatility σ 47% · implied rate exceeded in 4/7 yrs
Central path = implied 8.6%/yr growth; shaded band = ±1σ (47%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
4/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on $46M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -4%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $128M covers all $23M of scheduled principal — no refinancing pressure. Scheduled principal only (excludes interest & revolver draws). As of 2012-12-31 (10-K).
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Interest last disclosed in FY2023 (no longer broken out).
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $719.0M 100.0% | $661.8M 100.0% | $607.5M 100.0% | $667.2M 100.0% | $579.8M 100.0% | $520.4M 100.0% | $392.8M 100.0% | $408.9M 100.0% | $302.2M 100.0% | $215.0M 100.0% |
| Cost of Revenue | $74.6M 10.4% | $77.9M 11.8% | $83.8M 13.8% | $87.2M 13.1% | — | $52.5M 10.1% | $16.7M 4.2% | $15.4M 3.8% | $15.2M 5.0% | $12.0M 5.6% |
| Cost of Products | — | — | — | — | — | — | — | — | $15.2M 5.0% | $12.0M 5.6% |
| Research & Development | $106.2M 14.8% | $108.8M 16.4% | $91.6M 15.1% | $74.6M 11.2% | $90.5M 15.6% | $76.0M 14.6% | $69.1M 17.6% | $89.2M 21.8% | $49.6M 16.4% | $42.8M 19.9% |
| Selling, General & Admin | $485.6M 67.5% | $321.6M 48.6% | $336.4M 55.4% | $377.2M 56.5% | $304.8M 52.6% | $200.7M 38.6% | $153.2M 39.0% | $154.7M 37.8% | $137.9M 45.6% | $106.0M 49.3% |
| Total Operating Expenses | $781.2M 108.7% | $580.2M 87.7% | $612.8M 100.9% | $621.1M 93.1% | $493.7M 85.2% | $346.7M 66.6% | $244.2M 62.2% | $264.5M 64.7% | $202.7M 67.1% | $160.8M 74.8% |
| Operating Income | -$62.3M -8.7% | $81.7M 12.3% | -$5.3M -0.9% | $46.1M 6.9% | $86.0M 14.8% | $173.7M 33.4% | $148.6M 37.8% | $144.4M 35.3% | $99.5M 32.9% | $54.2M 25.2% |
| Interest Expense | $0 0.0% | $0 0.0% | $2.4M 0.4% | $7.1M 1.1% | $19.7M 3.4% | $19.4M 3.7% | $18.2M 4.6% | $13.8M 3.4% | $134K 0.0% | $543K 0.3% |
| Interest & Investment Income | — | — | — | — | — | $18.7M 3.6% | $21.6M 5.5% | $13.8M 3.4% | $2.9M 0.9% | $1.5M 0.7% |
| Other Income (Expense), net | $13.3M 1.8% | $16.2M 2.4% | $8.0M 1.3% | $14.6M 2.2% | -$12.9M -2.2% | -$5.0M -1.0% | -$1.1M -0.3% | -$4.3M -1.0% | $1.1M 0.4% | -$3.8M -1.8% |
| Pretax Income | -$49.0M -6.8% | $97.9M 14.8% | $2.8M 0.5% | $60.7M 9.1% | $73.2M 12.6% | $168.6M 32.4% | $147.5M 37.6% | $140.2M 34.3% | $100.6M 33.3% | $50.4M 23.4% |
| Income Tax Expense | -$10.5M -1.5% | $24.0M 3.6% | $1.5M 0.2% | $32K 0.0% | $19.8M 3.4% | $41.7M 8.0% | $34.4M 8.8% | $29.2M 7.1% | $43.3M 14.3% | -$40.9M -19.0% |
| Net Income | -$38.6M -5.4% | $73.9M 11.2% | $1.3M 0.2% | $60.7M 9.1% | $53.4M 9.2% | $127.0M 24.4% | $113.1M 28.8% | $111.0M 27.1% | $57.3M 19.0% | $91.2M 42.4% |
| Per Share | ||||||||||
| EPS (Basic) | $-0.68 | $1.34 | $0.02 | $1.13 | $1.01 | $2.41 | $2.16 | $2.13 | $1.13 | $1.84 |
| EPS (Diluted) | $-0.68 | $1.32 | $0.02 | $1.04 | $0.98 | $2.36 | $2.10 | $2.05 | $1.08 | $1.76 |
| Weighted Avg Shares (Basic) | 56.5M | 55.1M | 54.5M | 53.7M | 53.1M | 52.6M | 52.4M | 52.0M | 50.8M | 49.5M |
| Weighted Avg Shares (Diluted) | 56.5M | 56.0M | 55.5M | 61.7M | 54.4M | 53.7M | 53.8M | 54.1M | 53.3M | 51.7M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 1085 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BCAX | $1.24T | — | — | — | — | — | — | -34.4% | -34.4% | — | 143 |
| LLY | $1.03T | 50.2× | — | 15.9× | 44.7% | 83.0% | 31.7% | 77.8% | 29.9% | — | 4,193 |
| AKTX | $894.1B | — | — | — | — | — | — | -61.1% | -61.1% | — | 1 |
| JNJ | $650.5B | 24.5× | — | 6.9× | 6.0% | 67.9% | 28.5% | 32.9% | 20.7% | — | 4,451 |
| ABBV | $467.1B | 111.9× | 33.4× | 7.6× | 8.6% | 70.2% | 6.9% | -129% | 6.6% | 4.2× | 3,895 |
| MRK | $368.2B | 20.2× | — | 5.7× | 1.3% | 74.8% | 28.1% | 34.7% | 17.9% | — | 3,594 |
| UNH | $339.9B | 28.4× | 19.7× | 0.8× | 11.8% | 88.7% | 2.7% | 12.0% | 6.8% | 3.9× | 2,891 |
| AZN | $257.7B | — | — | — | — | — | — | — | — | — | 1,248 |
| TMO | $248.2B | 37.1× | 31.9× | 5.6× | 3.9% | — | 15.0% | 12.6% | 7.0% | 4.9× | 2,481 |
| AMGN | $204.6B | 26.7× | 17.6× | 5.6× | 10.0% | 67.2% | 21.0% | 89.1% | 12.2% | 3.8× | 3,014 |
| GILD | $187.3B | 22.3× | 20.4× | 6.4× | 2.4% | 78.8% | 28.9% | 37.5% | 17.9% | 2.4× | 2,218 |
| ABT | $178.0B | 27.5× | 19.2× | 4.0× | 5.7% | 56.4% | 14.7% | 12.5% | 10.0% | 1.4× | 2,964 |
| PFE | $157.1B | 20.3× | — | 2.5× | -1.6% | 74.3% | 12.4% | 9.0% | 5.1% | — | 2,838 |
| DHR | $150.2B | 42.1× | 31.0× | 6.1× | 2.9% | 59.1% | 14.7% | 6.9% | 5.1% | 3.4× | 2,083 |
| ISRG | $136.2B | 48.7× | 37.5× | 13.5× | 20.5% | 66.0% | 28.4% | 16.0% | 16.0% | — | 2,190 |
| VRTX | $131.1B | 33.7× | 28.8× | 10.9× | 8.9% | 86.2% | 32.9% | 21.2% | 21.2% | — | 1,609 |
| BMY | $127.8B | 18.2× | — | 2.6× | -0.2% | 71.1% | 14.6% | 38.2% | 11.1% | — | 2,431 |
| MDT | $118.8B | 24.9× | 12.6× | 3.3× | 8.4% | 65.0% | 13.2% | 9.7% | 9.4% | 0.2× | 2,114 |
| CVS | $114.7B | 64.9× | 11.5× | 0.3× | 7.8% | 45.0% | 0.4% | 2.4% | 2.4% | 0.0× | 1,795 |
| SYK | $107.1B | 33.4× | 18.4× | 4.3× | 11.2% | 64.0% | 12.9% | 14.5% | 8.5% | 2.5× | 2,196 |
| MCK | $102.5B | 22.9× | 16.2× | 0.3× | 12.4% | 3.6% | 1.2% | -219% | 109% | 1.0× | 1,946 |
| HCA | $96.4B | 15.1× | — | 1.3× | 7.1% | — | 9.0% | -113% | 16.8% | — | 1,346 |
| ELV | $91.4B | 16.4× | 15.5× | 0.5× | 12.5% | 89.4% | 2.8% | 12.9% | 7.6% | 4.2× | 1,397 |
| REGN | $82.6B | 19.0× | 19.8× | 5.8× | 1.0% | — | 31.4% | 14.4% | 13.6% | 0.5× | 1,336 |
| CI | $72.7B | 12.4× | 5.5× | 0.3× | 11.2% | 21.8% | 2.2% | 14.3% | 14.1% | 0.0× | 1,583 |
| SUPN | $2.5B | — | 79.8× | 3.4× | 8.6% | 89.6% | -5.4% | -3.6% | -3.6% | — | 309 |
Peers = companies sharing SUPN's sector (Healthcare) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
EOD close · as of 2026-09-17
Where each multiple sits in its own 14-yr range · 59th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 3.8 | 4.2 | 10.1 | — | 13.1 | 13.8 | 11.8 | 10.4 |
| R&D | 21.8 | 17.6 | 14.6 | 15.6 | 11.2 | 15.1 | 16.4 | 14.8 |
| SG&A | 37.8 | 39.0 | 38.6 | 52.6 | 56.5 | 55.4 | 48.6 | 67.5 |
| Operating Income | 35.3 | 37.8 | 33.4 | 14.8 | 6.9 | -0.9 | 12.3 | -8.7 |
| Income Tax | 7.1 | 8.8 | 8.0 | 3.4 | 0.0 | 0.2 | 3.6 | -1.5 |
| Net Income | 27.1 | 28.8 | 24.4 | 9.2 | 9.1 | 0.2 | 11.2 | -5.4 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on SUPN: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.